These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Refocusing Neuroprotection in Cerebral Reperfusion Era: New Challenges and Strategies. Xiong XY; Liu L; Yang QW Front Neurol; 2018; 9():249. PubMed ID: 29740385 [TBL] [Abstract][Full Text] [Related]
7. New approaches to neuroprotective drug development. Fisher M Stroke; 2011 Jan; 42(1 Suppl):S24-7. PubMed ID: 21164111 [TBL] [Abstract][Full Text] [Related]
8. Impact of Collateral Status on Successful Revascularization in Endovascular Treatment: A Systematic Review and Meta-Analysis. Leng X; Fang H; Leung TW; Mao C; Xu Y; Miao Z; Liu L; Wong KS; Liebeskind DS Cerebrovasc Dis; 2016; 41(1-2):27-34. PubMed ID: 26579719 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Green AR Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S325-38. PubMed ID: 18059324 [TBL] [Abstract][Full Text] [Related]
10. The potential of drug repurposing combined with reperfusion therapy in cerebral ischemic stroke: A supplementary strategy to endovascular thrombectomy. Yang JL; Yang YR; Chen SD Life Sci; 2019 Nov; 236():116889. PubMed ID: 31610199 [TBL] [Abstract][Full Text] [Related]
11. Reperfusion Therapies in Acute Ischemic Stroke. Yeo LL; Tan BY; Yee W; Kulkarni A; Sharma VK Recent Pat CNS Drug Discov; 2015; 10(1):45-54. PubMed ID: 26129854 [TBL] [Abstract][Full Text] [Related]
13. Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. Rahme R; Yeatts SD; Abruzzo TA; Jimenez L; Fan L; Tomsick TA; Ringer AJ; Furlan AJ; Broderick JP; Khatri P J Neurosurg; 2014 Dec; 121(6):1354-8. PubMed ID: 25259569 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective delivery platforms as an adjunct to mechanical thrombectomy. Babadjouni RM; Walcott BP; Liu Q; Tenser MS; Amar AP; Mack WJ Neurosurg Focus; 2017 Apr; 42(4):E4. PubMed ID: 28366053 [TBL] [Abstract][Full Text] [Related]
15. Experimental models, neurovascular mechanisms and translational issues in stroke research. Lo EH Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S396-405. PubMed ID: 18157168 [TBL] [Abstract][Full Text] [Related]
16. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Gladstone DJ; Black SE; Hakim AM; Stroke; 2002 Aug; 33(8):2123-36. PubMed ID: 12154275 [TBL] [Abstract][Full Text] [Related]
17. Improving Reperfusion Therapies in the Era of Mechanical Thrombectomy. Linfante I; Cipolla MJ Transl Stroke Res; 2016 Aug; 7(4):294-302. PubMed ID: 27221511 [TBL] [Abstract][Full Text] [Related]
18. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Savitz SI; Fisher M Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989 [TBL] [Abstract][Full Text] [Related]
19. Experimental neuroprotection in ischemic stroke: a concise review. Rajah GB; Ding Y Neurosurg Focus; 2017 Apr; 42(4):E2. PubMed ID: 28366067 [TBL] [Abstract][Full Text] [Related]